Novartis will integrate the pharmaceuticals and oncology business units and create two separate commercial organizations with a stronger geographic focus — Innovative Medicines U.S. and Innovative Medicines International.
Triumeq, the first dispersible single-tablet regimen containing dolutegravir, increases age-appropriate treatment options for children living with HIV, the company said.
Thirty-five generic manufacturers have signed agreements with the MPP to produce low-cost, generic versions of Pfizer’s oral COVID-19 treatment nirmatrelvir in combination with ritonavir for 95 low- and middle-income countries.